Belite Bio, Inc SEC filings BLTE
Belite Bio, Inc has 214 filings in SEC EDGAR's recent list, going back to Dec 1, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 19, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 12, 2026 |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Jun 15, 2026 | Jun 12, 2026 |
| 6-K | Current report (foreign issuer) | May 20, 2026 | May 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Mar 31, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Mar 2, 2026 |
| 6-K | Current report (foreign issuer) | Jan 27, 2026 | Jan 27, 2026 |
| 6-K | Current report (foreign issuer) | Dec 2, 2025 | Dec 2, 2025 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Sep 8, 2025 |
| 6-K | Current report (foreign issuer) | Aug 11, 2025 | Aug 11, 2025 |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Jul 2, 2025 | Jul 2, 2025 |
| 6-K | Current report (foreign issuer) | May 21, 2025 | May 21, 2025 |
| 6-K | Current report (foreign issuer) | May 14, 2025 | May 13, 2025 |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Mar 28, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 18, 2025 |
| 6-K | Current report (foreign issuer) | Mar 17, 2025 | Mar 17, 2025 |
| 6-K | Current report (foreign issuer) | Mar 17, 2025 | Mar 17, 2025 |
| 6-K | Current report (foreign issuer) | Feb 27, 2025 | Feb 27, 2025 |
| 6-K | Current report (foreign issuer) | Feb 6, 2025 | Feb 6, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 12, 2024 |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Sep 3, 2024 | Sep 3, 2024 |
| 6-K | Current report (foreign issuer) | Aug 9, 2024 | Aug 9, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 13, 2024 |
| 6-K | Current report (foreign issuer) | Apr 26, 2024 | Apr 25, 2024 |
| 6-K | Current report (foreign issuer) | Mar 22, 2024 | Mar 22, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 11, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 11, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2023 | Nov 13, 2023 |
| 6-K | Current report (foreign issuer) | Nov 6, 2023 | Nov 6, 2023 |
| 6-K | Current report (foreign issuer) | Aug 9, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Jul 24, 2023 | Jul 20, 2023 |
| 6-K | Current report (foreign issuer) | Jun 16, 2023 | Jun 16, 2023 |
| 6-K | Current report (foreign issuer) | May 31, 2023 | May 30, 2023 |
| 6-K | Current report (foreign issuer) | May 30, 2023 | May 30, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 10, 2023 |
| 6-K | Current report (foreign issuer) | Apr 25, 2023 | Apr 25, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Dec 13, 2022 | Dec 13, 2022 |
| 6-K | Current report (foreign issuer) | Nov 18, 2022 | Nov 18, 2022 |
| 6-K | Current report (foreign issuer) | Oct 3, 2022 | Oct 1, 2022 |
| 6-K | Current report (foreign issuer) | Sep 16, 2022 | Sep 16, 2022 |
| 6-K | Current report (foreign issuer) | Aug 22, 2022 | Aug 22, 2022 |
| 6-K | Current report (foreign issuer) | Aug 11, 2022 | Aug 10, 2022 |
| 6-K | Current report (foreign issuer) | Jul 19, 2022 | Jul 19, 2022 |
| 6-K | Current report (foreign issuer) | May 12, 2022 | May 12, 2022 |
| 6-K | Current report (foreign issuer) | May 3, 2022 | May 31, 2022 |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLTE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1889109
- Former names
- BELITE BIO, INC (until Oct 30, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.